Welcome to Markets Desk, your midday read on the stories moving money and markets.
South Korea is deepening its defense relationship with American contractors, placing a one point two billion dollar parts order with Boeing to upgrade its fleet of Apache attack helicopters. The move signals Seoul's continued commitment to modernizing its military posture amid persistent regional tensions, and it's a meaningful revenue line for Boeing's defense segment at a time when that division needs the wins.
Shifting to biotech, MannKind Corporation scored a significant label expansion today as the FDA approved its inhaled insulin product Afrezza for children and adolescents aged six and older with both type one and type two diabetes. This is a genuine commercial catalyst for MannKind, a company that has long struggled to find its footing. Reaching the pediatric market opens a new patient population and gives the stock a credible growth narrative investors haven't had in a while.
And in semiconductors, Broadcom has quietly crossed two trillion dollars in market capitalization, surpassing Tesla in the process. Many generalist investors still underweight the name, but Broadcom's AI networking and custom chip business has been compounding at a pace that demands attention. This is no longer a story on the periphery — it's one of the defining valuations in technology right now.
That's the tape. Markets Desk, signing off the floor.
